newsfilter
← Latest News
Business Wire·

Athersys to Participate in International Stroke Conference and BioProcess International

Athersys, Inc. (NASDAQ:ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today its participation in two upcoming conferences, the